Nephropathy Disease

BASICS

DESCRIPTION

Renal parenchymal damage and dysfunction associated with disordered uric acid metabolism. Several syndromes can present.

  • Gout: Acute urate crystal-induced arthritis related to chronic hyperuricemia due to uric acid renal underexcretion in 80–90% and uric acid overproduction in 10–20%
  • Hyperuricemic acute renal failure: Precipitated by distal tubular obstruction resulting from acute massive overproduction of uric acid due to cell lysis. Serum uric acid usually greater than 15–20 mg/dL (0.88–1.18 mmol/L)
  • Uric acid nephrolithiasis: Most commonly seen in gouty patients who are uric acid overproducers and have hyperuricosuria. Frequency of stone formation increases with increasing serum uric acid levels and urinary uric acid excretion rates. About 22% of gouty patients will form uric acid stones
  • Hyperuricemia of chronic renal failure: Occurs when creatinine clearance is less than 15. Serum uric acid usually greater than 10 mg/dL. Secondary gout rare. Acute deterioration of renal function can be precipitated by an abrupt rise in serum uric acid
  • Chronic urate nephropathy: Renal insufficiency attributed to parenchymal damage secondary to medullary urate deposition. Bulk of evidence supports conclusion that typical gout or asymptomatic hyperuricemia are unlikely to lead to serious renal insufficiency. In patients with gout, renal insufficiency can usually be attributed to a complicating medical condition, most often hypertension, diabetes, renal vascular disease, obstructive uropathy, urinary tract infection, or lead intoxication
  • System(s) affected: Renal/Urologic
  • Genetics: N/A
  • Incidence/Prevalence in USA: Gout 0.3%, Hyperuricemia 5-10%
  • Predominant age: Adults
  • Predominant sex: Male > Female
SIGNS AND SYMPTOMS
  • Hyperuricemic acute renal failure
    • Precipitated by chemotherapy for leukemia or lymphoma
    • Precipitated by heat stress and exercise
    • Oliguria
    • Anuria
    • Anorexia, nausea, vomiting, encephalopathy and other manifestations of uremia
    • Hypertension
    • Anemia
    • Dehydration
  • Uric acid nephrolithiasis
    • Flank pain
    • Groin pain
    • Micro or gross hematuria
    • Anorexia
    • Nausea
    • Vomiting
    • Dehydration
  • Hyperuricemia of chronic renal failure
    • Established chronic renal failure with glomerular filtration rate (GFR) less than 15–20
    • Serum uric acid greater than 10 mg/dL chronically
    • Intercurrent cause of abrupt increase in serum uric acid
    • Acute decrease in GFR
    • Acute onset of uremic symptoms
CAUSES
  • Primary
    • Congenital gout, hypertension and hyperuricemia (autosomal dominant)
    • Congenital HGPRT deficiency (X-linked recessive)
    • Congenital PRPP overactivity (X-linked recessive)
    • Congenital glycogen storage disease, type I
  • Secondary
    • Lead intoxication
    • Diuretics
    • Cytotoxic chemotherapy in leukemia or lymphoma
    • Heat stress and exercise
    • Diabetic ketoacidosis
    • Starvation ketosis
    • Chronic myeloproliferative disease
    • Psoriasis
RISK FACTORS
  • Sudden increase in uric acid load
  • Dehydration
  • Urine pH less than 5
  • Hypertension
  • Diabetes mellitus
  • Renal insufficiency
  • Renal vascular disease

DIAGNOSIS

LABORATORY
  • Gout and hyperuricemia
    • Hyperuricemia
    • Hyperuricosuria in 10–20%
    • Decreased urinary ammonia production
  • Hyperuricemic acute renal failure
    • Serum uric acid greater than 15–20 mg/dL (0.88–1.18 mmol/L)
    • Rising BUN and creatinine
    • Urinary uric acid to creatinine ratio > 1
    • Uric acid crystals in urine
  • Uric acid nephrolithiasis
    • Uric acid crystals in urine
    • Urinary uric acid greater than 600–700 mg (3.54–4.13 mmol) per 24 hours (hyperuricosuria) on purine-free diet
    • Hyperuricemia
    • Microhematuria
    • Pyuria
    • Positive urine culture
    • Stone composition: uric acid or mixed uric acid and calcium oxalate or calcium phosphate
  • Hyperuricemia of chronic renal failure
    • Acute exacerbation of hyperuricemia with serum uric acid greater than 10 mg/dL (0.59 mmol/L)
    • Acute on chronic BUN and creatinine elevations

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS
  • Renal tophi – medullary monosodium urate deposits with inflammatory reaction and interstitial fibrosis
  • Poor correlation between severity of renal pathology and severity of gout
  • Tubulointerstitial nephritis with obstruction, recurrent infection or lead intoxication
SPECIAL TESTS
Stone analysis
IMAGING
  • IVP
  • Renal ultrasound
DIAGNOSTIC PROCEDURES
  • Cystoscopy and retrograde pyelography
  • Renal biopsy

TREATMENT

APPROPRIATE HEALTH CARE

Outpatient except for complicated nephrolithiasis and hyperuricemic acute renal failure

GENERAL MEASURES
  • Hydration to increase urine output
  • Normalize serum uric acid
  • Normalize renal uric acid excretion
  • Decrease uric acid production
  • Maintain urine pH greater than 6
  • Antibiotic treatment of urinary tract infection
  • Hyperuricemic acute renal failure
    • IV hydration
    • Hemodialysis
SURGICAL MEASURES

Uric acid nephrolithiasis: Cystoscopic or surgical stone removal for persistent ureteral obstruction

ACTIVITY

Limited during attacks of acute gouty arthritis

DIET
  • Purine restriction
  • Protein restriction
  • For nephrolithiasis, fluid intake adequate to produce urine output at least 2 L per day unless urine output is limited by acute or chronic renal failure
  • In acute renal failure restrict sodium for hypertension and potassium for hyperkalemia
PATIENT EDUCATION

Griffith, H.W.: Instructions for Patients. Philadelphia, W.B. Saunders Co., 1994

FOLLOW UP

PREVENTION/AVOIDANCE
  • Appropriate pretreatment prior to chemotherapy of leukemia or lymphoma
  • Avoid factors that can cause abrupt or persistent increases of serum uric acid or urinary uric acid excretion
  • Prompt treatment of urinary obstruction or infection
  • Control blood pressure in hypertensives
POSSIBLE COMPLICATIONS
  • Gout and hyperuricemia
    • No apparent renal complications
  • Hyperuricemic acute renal failure
    • Irreversible renal failure (end-stage renal disease)
    • Residual renal insufficiency
    • Persistent renal tubular functional defects
  • Uric acid nephrolithiasis
    • Urinary obstruction
    • Urinary infection
    • Renal insufficiency
  • Hyperuricemia of chronic renal failure
    • Progression to end-stage renal failure
EXPECTED COURSE AND PROGNOSIS
  • With effective drug therapy and general management prognosis is excellent in patients with gout, hyperuricemia, or nephrolithiasis
  • Development or progression of renal insufficiency should not occur unless due to underlying renal disease or associated medical conditions with adverse renal effects

MISCELLANEOUS

ASSOCIATED CONDITIONS
  • Hypertension
  • Diabetes mellitus
AGE-RELATED FACTORS

Pediatric: Gout and uric acid nephrolithiasis may have onset in infancy or childhood with HGPRT deficiency or PRPP overactivity
Geriatric: Renal insufficiency more likely due to age and associated medical conditions
Others: N/A

PREGNANCY

Women with nephrolithiasis have a slightly higher incidence of urinary tract infection, but no increase in stone formation rate

OTHER NOTES

N/A

ABBREVIATIONS

N/A

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.